Medical - Healthcare Plans
Compare Stocks
5 / 10Stock Comparison
CNC vs MOH vs UNH vs ELV vs HUM
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Plans
Medical - Healthcare Plans
Medical - Healthcare Plans
Medical - Healthcare Plans
CNC vs MOH vs UNH vs ELV vs HUM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Healthcare Plans | Medical - Healthcare Plans | Medical - Healthcare Plans | Medical - Healthcare Plans | Medical - Healthcare Plans |
| Market Cap | $26.15B | $10.01B | $330.28B | $80.15B | $28.76B |
| Revenue (TTM) | $198.10B | $45.08B | $449.71B | $200.41B | $137.20B |
| Net Income (TTM) | $-6.44B | $188M | $12.04B | $5.24B | $1.13B |
| Gross Margin | 14.9% | 9.6% | 18.8% | 23.2% | 14.0% |
| Operating Margin | -3.7% | 1.2% | 4.2% | 3.8% | 1.0% |
| Forward P/E | 15.7x | 37.3x | 19.9x | 13.8x | 26.8x |
| Total Debt | $18.78B | $3.95B | $78.39B | $33.23B | $12.94B |
| Cash & Equiv. | $17.89B | $4.25B | $24.36B | $9.49B | $4.20B |
CNC vs MOH vs UNH vs ELV vs HUM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Centene Corporation (CNC) | 100 | 79.9 | -20.1% |
| Molina Healthcare, … (MOH) | 100 | 103.4 | +3.4% |
| UnitedHealth Group … (UNH) | 100 | 119.4 | +19.4% |
| Elevance Health Inc. (ELV) | 100 | 125.5 | +25.5% |
| Humana Inc. (HUM) | 100 | 58.3 | -41.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CNC vs MOH vs UNH vs ELV vs HUM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CNC carries the broadest edge in this set and is the clearest fit for sleep-well-at-night.
- Lower volatility, beta 0.39, Low D/E 93.6%, current ratio 1.68x
- 19.4% revenue growth vs HUM's 10.1%
- Lower P/E (15.7x vs 26.8x)
- Beta 0.39 vs UNH's 0.59
Among these 5 stocks, MOH doesn't own a clear edge in any measured category.
UNH is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 25 yrs, beta 0.59, yield 2.4%
- 217.0% 10Y total return vs MOH's 323.6%
- Combined ratio 1.0 vs CNC's 1.0 (lower = better underwriting)
- 2.4% yield, 25-year raise streak, vs ELV's 1.9%, (2 stocks pay no dividend)
ELV ranks third and is worth considering specifically for growth exposure and defensive.
- Rev growth 12.6%, EPS growth -2.2%, 3Y rev CAGR 8.3%
- Beta 0.46, yield 1.9%, current ratio 1.24x
- 4.3% ROA vs CNC's -7.9%, ROIC 9.1% vs -21.6%
HUM is the clearest fit if your priority is momentum.
- -5.3% vs MOH's -39.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.4% revenue growth vs HUM's 10.1% | |
| Value | Lower P/E (15.7x vs 26.8x) | |
| Quality / Margins | Combined ratio 1.0 vs CNC's 1.0 (lower = better underwriting) | |
| Stability / Safety | Beta 0.39 vs UNH's 0.59 | |
| Dividends | 2.4% yield, 25-year raise streak, vs ELV's 1.9%, (2 stocks pay no dividend) | |
| Momentum (1Y) | -5.3% vs MOH's -39.9% | |
| Efficiency (ROA) | 4.3% ROA vs CNC's -7.9%, ROIC 9.1% vs -21.6% |
CNC vs MOH vs UNH vs ELV vs HUM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CNC vs MOH vs UNH vs ELV vs HUM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
UNH leads in 2 of 6 categories
CNC leads 1 • ELV leads 1 • MOH leads 0 • HUM leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
UNH leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH is the larger business by revenue, generating $449.7B annually — 10.0x MOH's $45.1B. UNH is the more profitable business, keeping 2.7% of every revenue dollar as net income compared to CNC's -3.3%. On growth, HUM holds the edge at +23.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $198.1B | $45.1B | $449.7B | $200.4B | $137.2B |
| EBITDAEarnings before interest/tax | -$5.9B | $710M | $23.2B | $8.9B | $2.2B |
| Net IncomeAfter-tax profit | -$6.4B | $188M | $12.0B | $5.2B | $1.1B |
| Free Cash FlowCash after capex | $6.3B | $251M | $19.7B | $6.5B | $1.3B |
| Gross MarginGross profit ÷ Revenue | +14.9% | +9.6% | +18.8% | +23.2% | +14.0% |
| Operating MarginEBIT ÷ Revenue | -3.7% | +1.2% | +4.2% | +3.8% | +1.0% |
| Net MarginNet income ÷ Revenue | -3.3% | +0.4% | +2.7% | +2.6% | +0.8% |
| FCF MarginFCF ÷ Revenue | +3.2% | +0.6% | +4.4% | +3.2% | +0.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.1% | -3.1% | +2.0% | +2.6% | +23.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +18.3% | -95.0% | +0.7% | -16.8% | -4.6% |
Valuation Metrics
CNC leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 14.7x trailing earnings, ELV trades at a 47% valuation discount to UNH's 27.5x P/E. On an enterprise value basis, MOH's 10.0x EV/EBITDA is more attractive than UNH's 16.5x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $26.2B | $10.0B | $330.3B | $80.1B | $28.8B |
| Enterprise ValueMkt cap + debt − cash | $27.0B | $9.7B | $384.3B | $103.9B | $37.5B |
| Trailing P/EPrice ÷ TTM EPS | -3.89x | 21.54x | 27.50x | 14.69x | 24.34x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.70x | 37.27x | 19.87x | 13.79x | 26.82x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 2.12x | — |
| EV / EBITDAEnterprise value multiple | — | 9.95x | 16.48x | 10.76x | 16.47x |
| Price / SalesMarket cap ÷ Revenue | 0.13x | 0.22x | 0.74x | 0.40x | 0.22x |
| Price / BookPrice ÷ Book value/share | 1.30x | 2.40x | 3.26x | 1.86x | 1.63x |
| Price / FCFMarket cap ÷ FCF | 6.05x | — | 20.55x | 25.25x | 76.69x |
Profitability & Efficiency
Evenly matched — MOH and ELV each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
ELV delivers a 11.9% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-29 for CNC. HUM carries lower financial leverage with a 0.73x debt-to-equity ratio, signaling a more conservative balance sheet compared to MOH's 0.97x. On the Piotroski fundamental quality scale (0–9), CNC scores 6/9 vs MOH's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -28.6% | +4.4% | +11.5% | +11.9% | +6.2% |
| ROA (TTM)Return on assets | -7.9% | +1.2% | +3.9% | +4.3% | +2.2% |
| ROICReturn on invested capital | -21.6% | +17.4% | +9.2% | +9.1% | +4.1% |
| ROCEReturn on capital employed | -14.6% | +9.8% | +9.7% | +8.2% | +4.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 | 6 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.94x | 0.97x | 0.77x | 0.75x | 0.73x |
| Net DebtTotal debt minus cash | $889M | -$298M | $54.0B | $23.7B | $8.7B |
| Cash & Equiv.Liquid assets | $17.9B | $4.2B | $24.4B | $9.5B | $4.2B |
| Total DebtShort + long-term debt | $18.8B | $4.0B | $78.4B | $33.2B | $12.9B |
| Interest CoverageEBIT ÷ Interest expense | -9.03x | 2.12x | 4.71x | 5.39x | 3.08x |
Total Returns (Dividends Reinvested)
ELV leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ELV five years ago would be worth $10,243 today (with dividends reinvested), compared to $5,570 for HUM. Over the past 12 months, HUM leads with a -5.3% total return vs MOH's -39.9%. The 3-year compound annual growth rate (CAGR) favors ELV at -5.8% vs HUM's -22.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +26.8% | +7.7% | +8.8% | +4.7% | -9.1% |
| 1-Year ReturnPast 12 months | -11.4% | -39.9% | -7.9% | -9.7% | -5.3% |
| 3-Year ReturnCumulative with dividends | -22.6% | -35.8% | -21.4% | -16.3% | -53.2% |
| 5-Year ReturnCumulative with dividends | -18.9% | -26.9% | -2.8% | +2.4% | -44.3% |
| 10-Year ReturnCumulative with dividends | +74.6% | +323.6% | +217.0% | +202.3% | +52.9% |
| CAGR (3Y)Annualised 3-year return | -8.2% | -13.8% | -7.7% | -5.8% | -22.4% |
Risk & Volatility
Evenly matched — MOH and UNH each lead in 1 of 2 comparable metrics.
Risk & Volatility
MOH is the less volatile stock with a -0.04 beta — it tends to amplify market swings less than UNH's 0.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UNH currently trades 88.8% from its 52-week high vs MOH's 57.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.39x | -0.04x | 0.59x | 0.46x | 0.56x |
| 52-Week HighHighest price in past year | $64.15 | $333.00 | $409.70 | $424.24 | $315.35 |
| 52-Week LowLowest price in past year | $25.08 | $121.06 | $234.60 | $273.71 | $163.11 |
| % of 52W HighCurrent price vs 52-week peak | +82.6% | +57.7% | +88.8% | +87.0% | +76.0% |
| RSI (14)Momentum oscillator 0–100 | 83.9 | 79.6 | 83.3 | 76.4 | 73.2 |
| Avg Volume (50D)Average daily shares traded | 5.7M | 1.4M | 8.1M | 1.9M | 1.6M |
Analyst Outlook
UNH leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CNC as "Buy", MOH as "Buy", UNH as "Buy", ELV as "Buy", HUM as "Hold". Consensus price targets imply 5.9% upside for UNH (target: $385) vs -13.6% for MOH (target: $166). For income investors, UNH offers the higher dividend yield at 2.39% vs HUM's 1.49%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $51.00 | $166.09 | $385.43 | $382.38 | $246.00 |
| # AnalystsCovering analysts | 43 | 38 | 52 | 37 | 44 |
| Dividend YieldAnnual dividend ÷ price | — | — | +2.4% | +1.9% | +1.5% |
| Dividend StreakConsecutive years of raises | 1 | — | 25 | 15 | 0 |
| Dividend / ShareAnnual DPS | — | — | $8.70 | $6.89 | $3.56 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.8% | +10.0% | +1.7% | +3.3% | +0.5% |
UNH leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). CNC leads in 1 (Valuation Metrics). 2 tied.
CNC vs MOH vs UNH vs ELV vs HUM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CNC or MOH or UNH or ELV or HUM a better buy right now?
For growth investors, Centene Corporation (CNC) is the stronger pick with 19.
4% revenue growth year-over-year, versus 10. 1% for Humana Inc. (HUM). Elevance Health Inc. (ELV) offers the better valuation at 14. 7x trailing P/E (13. 8x forward), making it the more compelling value choice. Analysts rate Centene Corporation (CNC) a "Buy" — based on 43 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CNC or MOH or UNH or ELV or HUM?
On trailing P/E, Elevance Health Inc.
(ELV) is the cheapest at 14. 7x versus UnitedHealth Group Incorporated at 27. 5x. On forward P/E, Elevance Health Inc. is actually cheaper at 13. 8x.
03Which is the better long-term investment — CNC or MOH or UNH or ELV or HUM?
Over the past 5 years, Elevance Health Inc.
(ELV) delivered a total return of +2. 4%, compared to -44. 3% for Humana Inc. (HUM). Over 10 years, the gap is even starker: MOH returned +323. 6% versus HUM's +52. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CNC or MOH or UNH or ELV or HUM?
By beta (market sensitivity over 5 years), Molina Healthcare, Inc.
(MOH) is the lower-risk stock at -0. 04β versus UnitedHealth Group Incorporated's 0. 59β — meaning UNH is approximately -1702% more volatile than MOH relative to the S&P 500. On balance sheet safety, Humana Inc. (HUM) carries a lower debt/equity ratio of 73% versus 97% for Molina Healthcare, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CNC or MOH or UNH or ELV or HUM?
By revenue growth (latest reported year), Centene Corporation (CNC) is pulling ahead at 19.
4% versus 10. 1% for Humana Inc. (HUM). On earnings-per-share growth, the picture is similar: Humana Inc. grew EPS -1. 4% year-over-year, compared to -315. 8% for Centene Corporation. Over a 3-year CAGR, MOH leads at 12. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CNC or MOH or UNH or ELV or HUM?
Elevance Health Inc.
(ELV) is the more profitable company, earning 2. 8% net margin versus -3. 4% for Centene Corporation — meaning it keeps 2. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus -3. 9% for CNC. At the gross margin level — before operating expenses — ELV leads at 25. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CNC or MOH or UNH or ELV or HUM more undervalued right now?
On forward earnings alone, Elevance Health Inc.
(ELV) trades at 13. 8x forward P/E versus 37. 3x for Molina Healthcare, Inc. — 23. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UNH: 5. 9% to $385. 43.
08Which pays a better dividend — CNC or MOH or UNH or ELV or HUM?
In this comparison, UNH (2.
4% yield), ELV (1. 9% yield), HUM (1. 5% yield) pay a dividend. CNC, MOH do not pay a meaningful dividend and should not be held primarily for income.
09Is CNC or MOH or UNH or ELV or HUM better for a retirement portfolio?
For long-horizon retirement investors, Molina Healthcare, Inc.
(MOH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 04), +323. 6% 10Y return). Both have compounded well over 10 years (MOH: +323. 6%, CNC: +74. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CNC and MOH and UNH and ELV and HUM?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CNC is a mid-cap high-growth stock; MOH is a mid-cap quality compounder stock; UNH is a large-cap quality compounder stock; ELV is a mid-cap deep-value stock; HUM is a mid-cap quality compounder stock. UNH, ELV, HUM pay a dividend while CNC, MOH do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.